STAR Evening News | Hao Europe Borg Holdings' shareholder control changes, stocks to resume trading tomorrow, Suzhou Veichi Electric plans to establish Asia Vets robot&automation project
1. As an electric autos company, BYD Company Limited's quarterly revenue exceeded Tesla for the first time; 2. Six departments: promoting the installation of photovoltaic systems on existing building roofs; 3. Three departments: supporting the IPO financing of relevant enterprises that meet the conditions of new materials big datacenter.
Delayed hospital purchases, sluggish non-rigid medical demand, and other factors dragged down shenzhen mindray bio-medical electronics' Q3 net income by 9.31% | Financial report watch
Due to factors such as delayed hospital procurement, tight hospital construction funds, and sluggish non-rigid medical demand, in the third quarter, Shenzhen Mindray Bio-Medical Electronics' net income decreased by 9.31% year-on-year, while total revenue increased by 1.43% year-on-year. In the second interim profit distribution in 2024, Shenzhen Mindray Bio-Medical Electronics will distribute 16.50 yuan for every 10 shares.
R&D expenses continue to rise, autobio diagnostics once again embroiled in a whirlpool of disputes | interpretations
①In the first three quarters of this year, the revenue and net income attributable to shareholders of Autobio Diagnostics have both increased to a certain extent; ②The company has further increased its investment in research and development, with multiple products obtaining medical instruments registration certificates.
The reversal of previously recognized share-based payment expenses and significant increase in government subsidies led to a more than threefold increase in net income for Aohua Endoscopy in Q3.
Due to the third quarter reversal of previously recognized share-based payment expenses, coupled with large government subsidies, Aohua Endoscopy achieved a third-quarter net income attributable to the parent company of 31.6414 million yuan, a year-on-year increase of 345.17%. In the field of soft endoscopes where foreign manufacturers have a market monopoly, Aohua Endoscopy not only holds a place, but its products have also entered the markets of Germany, the united kingdom, south korea, and other countries.
Xishan Technology: Repurchase three times costing 0.44 billion yuan. The "consumables" transformation of surgical equipment blades is driving revenue growth | Direct hit at the shareholder meeting.
Since December of last year, Xishan Technology has conducted three rounds of share buybacks. Among them, two rounds have been completed, and the third round is ongoing. As of now, the company has repurchased a total of 0.44 billion yuan worth of shares. The company's personnel stated that with changes in the external environment and the usage cycle of power surgical device equipment itself, there is expected market space for disposable surgical consumables in the second half of the year.
Has the source of funds for the controlling shareholder's shareholding changed? Beijing Balance Medical Technology Co., Ltd. insider: Self-financing can also be done through "special shareholding loans".
①Company insiders have expressed that beijing balance medical technology co., ltd. plans to increase its shareholding through self-raised funds, not ruling out the possibility of increasing company stocks through bank's "stock shareholding special loans". ②Jin Lei, the director of beijing balance medical technology co., ltd., believes that against the backdrop of a sluggish performance in the medical instruments sector, the company's stock price is undervalued by the market.